Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.11
- Piotroski Score 3.00
- Grade Buy
- Symbol (VOR)
- Company Vor Biopharma Inc.
- Price $0.78
- Changes Percentage (-1.98%)
- Change -$0.02
- Day Low $0.77
- Day High $0.81
- Year High $3.14
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $6.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.77
- Trailing P/E Ratio -0.69
- Forward P/E Ratio -0.69
- P/E Growth -0.69
- Net Income $-117,863,000
Income Statement
Quarterly
Annual
Latest News of VOR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
MLB free agency odds: Favorites to land top free agents Soto, Burnes, and more
Teams are already strategizing to attract top free agents for the 2025 MLB season. With players waiting for suitable contracts, a competitive free agency period is expected, featuring big names like J...
By USA Today | 16 hours ago -
Bo Nix and Broncos favored to finally beat Raiders in Las Vegas
Broncos won their last meeting against the Raiders. Bo Nix is excelling as a rookie QB, while TE Brock Bowers shines in the offense. The matchup will feature key players like Mike McGlinchey and Maxx ...
By AP NEWS | 22 hours ago -
Pop star Ed Sheeran helps favorite soccer team sign player before getting on stage with Taylor Swift
Ed Sheeran, a shareholder at Ipswich Town, helped the team sign a player by connecting with him over a Zoom call before his concert with Taylor Swift. Sheeran's involvement in recruitment shows his co...
By AP NEWS | 1 day ago
